Pfizer is cutting costs, growing its core business, and trading at a deep discount despite looming patent losses and COVID ...

Pfizer has concluded a global licensing agreement with 3SBio, excluding China, which grants it exclusive rights for the 3SBio’s SSGJ-707.

If you're experiencing workplace loneliness, recognize that your need to feel seen and heard isn't a luxury; it's fundamental ...

I find that sustained success now demands a new kind of leadership grounded in agility, strategic foresight and courage.

Pfizer is on the brink of a major rebound, transitioning focus to oncology and potential blockbuster drugs after a sharp drop in COVID-related revenues. Pfizer’s stock has plummeted over 50% in the ...

In the field of organizational psychology, the rapidly increasing multicultural composition of today’s workforces presents complex challenges for fostering ...

I didn’t leave medicine behind when I stepped out of the operating room. I carried its lessons with me into leadership. Today, I see myself as a leader who also happens to be a physician, and that ...

Modern Retina provides ophthalmology professionals with the latest advancements, research, and expert insights in retinal ...

According to TalentSmart, 90% of high performers score high in emotional intelligence. That’s no accident. Great leaders ...

Pfizer (PFE), a global pharmaceutical giant that was once a pandemic darling, is now facing turbulence. Following a period of extraordinary vaccine-driven revenue, the company now faces a more ...

New York City mayoral candidate Zohran Mamdani told business leaders that he would begin to discourage the use of the phrase ...

Pfizer and Astellas’ Xtandi (enzalutamide) has improved overall survival (OS) in patients with nmHSPC, but only as a combination therapy.